William Blair Upgrades Larimar Therapeutics (LRMR) to Outperform
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $4.27 -2.29%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
William Blair analyst Myles Minter upgraded Larimar Therapeutics (NASDAQ: LRMR) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Larimar Therapeutics click here. For more ratings news on Larimar Therapeutics click here.
Shares of Larimar Therapeutics closed at $3.20 yesterday.
You May Also Be Interested In
- Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'
- Wells Fargo Upgrades SM Energy (SM) to Overweight
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
